Processa Pharmaceuticals PCSA
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 2.53 | 3 | -83.2 | -3 | -54.75 | 5 |
| 2025Q4 | 2.88 | 6 | -58.87 | -3 | -43.63 | 8 |
| 2025Q3 | 4.8 | 6 | -57.57 | -3 | -43.6 | 8 |
| 2025Q2 | 5.13 | 6 | -81.67 | -4 | -60.56 | 8 |
| 2025Q1 | 9.25 | 4 | -108.52 | -3 | -70.51 | 5 |
| 2024Q4 | 22.1 | 2 | -100.76 | -3 | -66.8 | 3 |
| 2024Q3 | 34.25 | 4 | -69.47 | -3 | -53.97 | 5 |
| 2024Q2 | 56 | 6 | -40.38 | -3 | -34.31 | 8 |
| 2024Q1 | 59.13 | 9 | -39.3 | -3 | -34.66 | 10 |
| 2023Q4 | 167.3 | 5 | -39.57 | -2 | -34.68 | 6 |
| 2023Q3 | 125.1 | 7 | -25.5 | -2 | -22.91 | 8 |
| 2023Q2 | 248.75 | 9 | -27.07 | -3 | -23.2 | 10 |
| 2023Q1 | 250.05 | 10 | -45.67 | -4 | -38.21 | 12 |
| 2022Q4 | 550 | 7 | -105.31 | -13 | -95.59 | 9 |
| 2022Q3 | 1130 | 17 | -32.26 | -6 | -29.9 | 19 |
| 2022Q2 | 1405 | 20 | -23.84 | -5 | -22.47 | 22 |
| 2022Q1 | 1505 | 23 | -13.25 | -3 | -12.71 | 24 |
| 2021Q4 | 2450 | 25 | -12.09 | -3 | -11.48 | 26 |
| 2021Q3 | 4285 | 27 | -10.58 | -3 | -9.93 | 29 |
| 2021Q2 | 4095 | 29 | -10.42 | -3 | -9.79 | 31 |